PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
03-Oct-2024 UK’s Largest Menopause Event, PAUSE Live, Takes Major Step Forward for Womankind PAUSE Live
03-Oct-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Janssen-Cilag International NV
01-Oct-2024 Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia Kyowa Kirin
01-Oct-2024 Helios Global Group, a leading full-service global healthcare communications provider, announces next stage of investment by Telemos Capital to support ambitious future growth Helios Global Group
01-Oct-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers ProteoNic
01-Oct-2024 AlzeCure's abstract on ACD856's anti-inflammatory effects to be presented at a leading Alzheimer's conference AlzeCure Pharma AB (publ)
01-Oct-2024 AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team AstronauTx Ltd
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan Nxera Pharma
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan Nxera Pharma
01-Oct-2024 DULAS’S NEW REFRIGERATION RANGE ADDRESSES STAGGERING VACCINE LOSSES CAUSED BY COLD CHAIN FAILURES Dulas Life Sciences
01-Oct-2024 Cherwell’s new Microbiology Product Specialist to share insights on EM for pharmaceutical quality assurance at QATS Symposium CHERWELL LABORATORIES
01-Oct-2024 PureTech to Present at CHEST 2024 Annual Meeting PureTech Health
01-Oct-2024 Beckman Coulter Life Sciences Names Joe Fox President Beckman Coulter Life Sciences
27-Sep-2024 Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Sanofi
27-Sep-2024 During European Myeloma Day, MPE highlights the importance of improving access to clinical trials Myeloma Patients Europe